Literature DB >> 16077166

Tumor necrosis factor alpha (TNF) suppresses cAMP response element (CRE) activity and nuclear CRE binding protein in MA-10 mouse Leydig tumor cells.

Koji Y Arai1, Katherine F Roby, Paul F Terranova.   

Abstract

TNF is known to suppress gonadotropin-induced steroid secretion by Leydig cells. However, the mechanisms by which this occurs are largely unknown. Because expression of many steroidogenic proteins is regulated by the PKA pathway, effects of TNF on CRE activity were examined using MA-10 mouse Leydig tumor cells. The cells were transfected with a CRE-luciferase construct, and stimulated with either LH or 8Br-cAMP in the presence or absence of TNF. TNF suppressed, LH-stimulated and 8Br-cAMP stimulated CRE activity. TNF also suppressed CRE activity stimulated with a PKA expression vector. Further experiments suggested that the effect of TNF on CRE activity was not mediated by the NF-kappaB pathway. TNF did not affect levels of either CREB or phospho-CREB in whole cell lysates; however, TNF decreased both CREB and phospho-CREB in nuclear extracts in a time-dependent manner. The decrease in nuclear CREB is likely to be a major mechanism of the suppressive effects of TNF on steroidogenesis in MA-10 Leydig cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077166     DOI: 10.1385/ENDO:27:1:017

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  45 in total

1.  Transcriptional activation by NF-kappaB requires multiple coactivators.

Authors:  K A Sheppard; D W Rose; Z K Haque; R Kurokawa; E McInerney; S Westin; D Thanos; M G Rosenfeld; C K Glass; T Collins
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Decreased catalytic subunit mRNA levels and altered catalytic subunit mRNA structure in a cAMP-resistant Chinese hamster ovary cell line.

Authors:  P Howard; K H Day; K E Kim; J Richardson; J Thomas; I Abraham; R D Fleischmann; M M Gottesman; R A Maurer
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

3.  Src tyrosine kinase regulates CYP17 expression and androstenedione secretion in theca-enriched mouse ovarian cells.

Authors:  Gaurav Chaturvedi; Koji Arai; Darlene Limback; Katherine F Roby; Paul F Terranova
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

Review 4.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

5.  Tumor necrosis factor-alpha inhibits leydig cell steroidogenesis through a decrease in steroidogenic acute regulatory protein expression.

Authors:  C Mauduit; F Gasnier; C Rey; M A Chauvin; D M Stocco; P Louisot; M Benahmed
Journal:  Endocrinology       Date:  1998-06       Impact factor: 4.736

6.  Involvement of tumor necrosis factor-alpha in the pathogenesis of autoimmune orchitis in rats.

Authors:  María O Suescun; Claudia Rival; María S Theas; Ricardo S Calandra; Livia Lustig
Journal:  Biol Reprod       Date:  2002-12-27       Impact factor: 4.285

7.  Regulation of gonadotropin receptors and gonadotropin responses in a clonal strain of Leydig tumor cells by epidermal growth factor.

Authors:  M Ascoli
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

8.  Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans.

Authors:  J G Cannon; J S Friedberg; J A Gelfand; R G Tompkins; J F Burke; C A Dinarello
Journal:  Crit Care Med       Date:  1992-10       Impact factor: 7.598

9.  Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.

Authors:  L D Kerr; L J Ransone; P Wamsley; M J Schmitt; T G Boyer; Q Zhou; A J Berk; I M Verma
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

10.  Pituitary-testicular axis dysfunction in burned men.

Authors:  A V Vogel; G T Peake; R T Rada
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.